Gritstone

-$0.40 (-5.97%) As of 7:18 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gritstone and other ETFs, options, and stocks.

About GRTS

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

CEO
Andrew R. Allen
Employees
169
Headquarters
Emeryville, California
Founded
2015

GRTS Key Statistics

Market Cap
450.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
713.17K
High Today
$6.67
Low Today
$6.23
Open Price
$6.60
Volume
645.39K
52 Week High
$35.20
52 Week Low
$2.54

GRTS Earnings

-$0.77
-$0.48
-$0.19
$0.10
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure